ATE335008T1 - Eisen-dextrin verbindung zur behandlung von anämien durch eisenmangel - Google Patents

Eisen-dextrin verbindung zur behandlung von anämien durch eisenmangel

Info

Publication number
ATE335008T1
ATE335008T1 AT03746252T AT03746252T ATE335008T1 AT E335008 T1 ATE335008 T1 AT E335008T1 AT 03746252 T AT03746252 T AT 03746252T AT 03746252 T AT03746252 T AT 03746252T AT E335008 T1 ATE335008 T1 AT E335008T1
Authority
AT
Austria
Prior art keywords
iron
treatment
anemia due
dextrin compound
deficiency
Prior art date
Application number
AT03746252T
Other languages
English (en)
Inventor
Hans Berg Andreasen
Lars Christensen
Original Assignee
Pharmacosmos Holding As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacosmos Holding As filed Critical Pharmacosmos Holding As
Application granted granted Critical
Publication of ATE335008T1 publication Critical patent/ATE335008T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B30/00Preparation of starch, degraded or non-chemically modified starch, amylose, or amylopectin
    • C08B30/12Degraded, destructured or non-chemically modified starch, e.g. mechanically, enzymatically or by irradiation; Bleaching of starch
    • C08B30/18Dextrin, e.g. yellow canari, white dextrin, amylodextrin or maltodextrin; Methods of depolymerisation, e.g. by irradiation or mechanically
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT03746252T 2002-04-09 2003-04-08 Eisen-dextrin verbindung zur behandlung von anämien durch eisenmangel ATE335008T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200200512 2002-04-09

Publications (1)

Publication Number Publication Date
ATE335008T1 true ATE335008T1 (de) 2006-08-15

Family

ID=28459423

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03746252T ATE335008T1 (de) 2002-04-09 2003-04-08 Eisen-dextrin verbindung zur behandlung von anämien durch eisenmangel

Country Status (23)

Country Link
US (1) US20030191090A1 (de)
EP (1) EP1492821B1 (de)
JP (1) JP4520748B2 (de)
KR (1) KR20040104560A (de)
CN (1) CN1309741C (de)
AR (1) AR039396A1 (de)
AT (1) ATE335008T1 (de)
AU (1) AU2003226923B2 (de)
BR (1) BR0308773A (de)
CA (1) CA2480365A1 (de)
DE (1) DE60307249T2 (de)
DK (1) DK1492821T3 (de)
EA (1) EA006720B1 (de)
ES (1) ES2270070T3 (de)
MX (1) MXPA04009770A (de)
NO (1) NO20044131L (de)
NZ (1) NZ535761A (de)
PL (1) PL373403A1 (de)
PT (1) PT1492821E (de)
SI (1) SI1492821T1 (de)
UA (1) UA79452C2 (de)
WO (1) WO2003087164A1 (de)
ZA (1) ZA200407658B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
WO2005087216A2 (de) * 2004-03-12 2005-09-22 Eberhard-Karls-Universität Tübingen Behandlung von anämischen zuständen durch inhibierung der erythrozytenapoptose
JP4550543B2 (ja) * 2004-10-07 2010-09-22 松谷化学工業株式会社 鉄、マグネシウム又は亜鉛成分に対する食品用マスキング剤
MX2007009588A (es) 2005-02-09 2007-09-12 Vifor Int Ag Uso de compuestos de complejo de hierro(iii).
EP1757299A1 (de) * 2005-08-25 2007-02-28 Vifor (International) Ag Eisen(III)-Komplexverbindungen zur Behandlung von Eisenmangel-Zuständen bei Patienten mit chronisch-entzündlicher Darmerkrankung
EP1790356A1 (de) * 2005-11-24 2007-05-30 Vifor (International) Ag Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en)
PT1973549T (pt) 2006-01-06 2016-10-25 Luitpold Pharm Inc Métodos e composições para administração de ferro
US20080132465A1 (en) * 2006-12-05 2008-06-05 Vincent Windisch Apparatus and method for isolating iron components from serum
LT3156075T (lt) 2009-03-25 2021-01-11 Pharmacosmos Holding A/S Oligosacharidas ir jo paruošimo būdas
CN106176808A (zh) 2010-10-19 2016-12-07 长春纳米生技公司 金属离子纳米簇组合物
WO2012104204A1 (en) 2011-01-31 2012-08-09 Vifor (International) Ag Iron-carbohydrate complex compounds for the intravenous therapy of malaria
CA2849926C (en) * 2011-10-13 2020-07-21 Vidasym, Inc. Iron-fiber composition, preparation and uses thereof
WO2014138016A1 (en) 2013-03-08 2014-09-12 Vidasym, Inc. Metal ion-functional fiber component complex compositions, preparation and uses thereof
EP2997968A1 (de) 2014-09-22 2016-03-23 Ioulia Tseti Eisen-(III)-Hydroxidkomplexe mit aktivierten Glucosesirups und Verfahren zur Herstellung davon
US10258647B2 (en) 2015-09-01 2019-04-16 Particle Dynamics International, Llc Iron-polysaccharide complexes and methods for the preparation thereof
WO2018198135A1 (en) * 2017-04-26 2018-11-01 Mylan Laboratories Ltd. Improved process for the preparation of iron complex
CN107519198A (zh) * 2017-07-21 2017-12-29 南通市第人民医院 一种右旋糖酐铁注射液及其制备方法
EP3932535A1 (de) * 2020-07-01 2022-01-05 Vifor Fresenius Medical Care Renal Pharma, Ltd. Verfahren zur herstellung von durch kohlenhydrate und/oder huminsäure stabilisierten mehrkernigen eisenverbindungen
US20260108551A1 (en) * 2021-08-03 2026-04-23 Pharmacosmos Holding A/S Iron complex compounds for subcutaneous use in therapy of iron deficiency in companion animals
WO2026017897A1 (en) 2024-07-18 2026-01-22 Malian Biologicals Gmbh Iron supplementation in affective disorders and/or post-traumatic stress disorder (ptsd) and/or serotonin-dependent diseases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1293144B (de) * 1964-11-04 1969-04-24 Hausmann Ag Labor Verfahren zur Herstellung von Komplexverbindungen des Eisens mit Sorbit, Gluconsaeure und einem Oligosaccharid
GB1183940A (en) * 1966-10-22 1970-03-11 Fisons Pharmaceuticals Ltd Ferric Hydroxide Complexes
ES360433A1 (es) * 1968-11-20 1970-11-16 Rocador Sa Procedimiento para la fabricacion de un compuesto de hierrotrivalente apropiado para administracion por via oral.
US3686397A (en) * 1970-05-18 1972-08-22 Mueller Arthur Parenteral iron preparations
JPS6039681B2 (ja) * 1976-01-01 1985-09-07 日本臓器製薬株式会社 デキストリン・クエン酸・第二鉄多核複合体及び該複合体を含有する非経口用鉄剤
DE3422249A1 (de) * 1984-06-15 1985-12-19 Pfeifer & Langen, 5000 Köln Wasserloesliches eisendextran und verfahren zu seiner herstellung
JPS6128502A (ja) * 1985-04-06 1986-02-08 Nippon Zoki Pharmaceut Co Ltd デキストリン・ヒドロキシカルボン酸・第二鉄多核複合体の製造方法
US5102652A (en) * 1986-07-03 1992-04-07 Advanced Magnetics Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
US4827945A (en) * 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
DK172860B1 (da) * 1998-03-25 1999-08-16 Pharmacosmos Holding As Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman

Also Published As

Publication number Publication date
NO20044131L (no) 2004-09-29
EP1492821A1 (de) 2005-01-05
UA79452C2 (en) 2007-06-25
DE60307249T2 (de) 2007-03-15
DK1492821T3 (da) 2006-11-27
PL373403A1 (en) 2005-08-22
JP4520748B2 (ja) 2010-08-11
WO2003087164A1 (en) 2003-10-23
EA006720B1 (ru) 2006-04-28
ZA200407658B (en) 2006-07-26
CA2480365A1 (en) 2003-10-23
CN1646568A (zh) 2005-07-27
NZ535761A (en) 2007-09-28
EA200401330A1 (ru) 2005-02-24
DE60307249D1 (de) 2006-09-14
AR039396A1 (es) 2005-02-16
HK1069589A1 (en) 2005-05-27
ES2270070T3 (es) 2007-04-01
SI1492821T1 (sl) 2006-12-31
EP1492821B1 (de) 2006-08-02
JP2005530863A (ja) 2005-10-13
US20030191090A1 (en) 2003-10-09
AU2003226923B2 (en) 2006-08-17
CN1309741C (zh) 2007-04-11
KR20040104560A (ko) 2004-12-10
BR0308773A (pt) 2005-02-09
MXPA04009770A (es) 2004-12-13
PT1492821E (pt) 2006-12-29
AU2003226923A1 (en) 2003-10-27

Similar Documents

Publication Publication Date Title
ATE335008T1 (de) Eisen-dextrin verbindung zur behandlung von anämien durch eisenmangel
DE602004026891D1 (de) Tlr7-liganden zur behandlung von hepatitis c
ATE250605T1 (de) Piperidin verbindung zur behandlung von psoriasis
DE602004020674D1 (de) 1-benzoyl-piperazin-derivate als glycin-aufnahmehemmer zur behandlung von psychosen
ATE515261T1 (de) Zusammensetzungen zur behandlung von diabetes
DE602005007717D1 (de) Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
DE602004002633D1 (de) Chromfreies Mittel zur Behandlung von Metalloberflächen
ATE551340T1 (de) Azabicyclisch- substituierte annelierte heteroaryl-verbinungen für die behandlung von krankheiten
DE60308885D1 (de) Herstellung von metallkomplexen
EP1765391A4 (de) Bakterielle zusammensetzungen zur behandlung von krebs
ATE410430T1 (de) 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
ATE451921T1 (de) Phenylindole zur behandlung von hiv
ATE498309T1 (de) Synergistische zusammensetzungen für die behandlung von saatgut
DE60032352D1 (de) Vorrichtungen zur behandlung von ischämie durch die bildung eines fibrinpfropfens
DE60307710D1 (de) Verfahren zur Herstellung von Eisenoxiden
ATE429218T1 (de) Pinolensäure zur behandlung von übergewicht
DE502004010131D1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
DE602004022153D1 (de) Verbindungen zur behandlung von obesitas
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
DE602004006118D1 (de) 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
DE60103835D1 (de) Chelate zur Behandlung von Helicobacter pylori Infektionen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1492821

Country of ref document: EP